-
Published on Sep 14, 2016
Proactive
Investors’ Stocktube chats to Mark Scott, chief executive of Cello
Group, the healthcare marking firm which as part of its interim results
today announced a 19% rise in its dividend.
Scott says the Cello Healthcare (CLL) division has been growing at a “considerable clip” and the group’s other unit, which provides digital solutions to large international corporates, is a similar pace - with sustainable rates of around 5% for both businesses.
“We service most of the big pharmaceutical companies globally, and an increasingly large proportion of large biotech businesses,” he says.
“These relationships are contracted long term, we have decent visibility, and occasionally if we’re lucky we pick up a new client entirely. But, it [the company’s growth] is more an issue of extending existing relationships and getting closer to prospective drug lines coming through.”
http://www.4-traders.com/CELLO-GROUP-PLC-4004929/
No comments:
Post a Comment